Agents for intravitreal administration to treat or prevent disorders of the eye

Details for Australian Patent Application No. 2005202579 (hide)

Owner Vitreo-Retinal Technologies, Inc.

Inventors Castillejos, David

Agent Davies Collison Cave

Pub. Number AU-A-2005202579

Parent 780299

Filing date 14 June 2005

Wipo publication date 7 July 2005

International Classifications

A61K 031/70 - Carbohydrates

A61K 031/17 - having the group NC(O)N or NC(S)N, e.g. urea, thiourea, carmustine

A61K 031/19

A61K 031/195

A61K 031/40 - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 031/495 - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 031/60 - Salicylic acid

Event Publications

30 June 2005 Complete Application Filed

7 July 2005 Application Open to Public Inspection

  Published as AU-A-2005202579

16 October 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005202580-Compressor with control and protection system

2005202578-Coating formulation having improved rheological properties